Top

European Journal of Nuclear Medicine and Molecular Imaging

Published in:

01-12-2014 | Letter to the Editor

Employing Bayesian approach to the intermediate risk categories of the Bethesda thyroid cytopathology reporting system: can FDG PET/CT find a strong enough evidence-base to be practised clinically as an adjunct?

Author: Sandip Basu

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 12/2014

Excerpt

Dear Sir, …

Morbelli S, Bagnasco M. Differentiated thyroid cancer incidentally detected by (18)F-FDG PET/CT: patient's future in a hot-spot? Eur J Nucl Med Mol Imaging. 2014;41(8):1479–81.PubMedCrossRef

Piccardo A, Puntoni M, Bertagna F, Treglia G, Foppiani L, Arecco F, et al. (18)F-FDG uptake as a prognostic variable in primary differentiated thyroid cancer incidentally detected by PET/CT: a multicentre study. Eur J Nucl Med Mol Imaging. 2014;41(8):1482–91.PubMedCrossRef

Nayan S, Ramakrishna J, Gupta MK. The proportion of malignancy in incidental thyroid lesions on 18-FDG PET study: a systematic review and meta-analysis. Otolaryngol Head Neck Surg. 2014;151(2):190–200.PubMedCrossRef

Gavriel H, Tang A, Eviatar E, Chan SW. Unfolding the role of PET FDG scan in the management of thyroid incidentaloma in cancer patients. Eur Arch Otorhinolaryngol. 2014. doi:10.1007/s00405-014-3120-5

American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer; Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19:1167–214.PubMedCrossRef

Cibas ES, Ali SZ; NCI Thyroid FNA State of the Science Conference. The Bethesda system for reporting thyroid cytopathology. Am J Clin Pathol. 2009;132(5):658–65.PubMedCrossRef

The Royal College of Pathologists. Guidance on the reporting of thyroid cytology specimens. London, UK: The Royal College of Pathologists. http://www.rcpath.org/Resources/RCPath/Migrated%20Resources/Documents/G/g089guidanceonthereportingofthyroidcytologyfinal.pdf. Accessed 29 August 2014.

Title: Employing Bayesian approach to the intermediate risk categories of the Bethesda thyroid cytopathology reporting system: can FDG PET/CT find a strong enough evidence-base to be practised clinically as an adjunct?
Author: Sandip Basu
Publication date: 01-12-2014
Publisher: Springer Berlin Heidelberg
Published in: European Journal of Nuclear Medicine and Molecular Imaging / Issue 12/2014
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-014-2908-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Employing Bayesian approach to the intermediate risk categories of the Bethesda thyroid cytopathology reporting system: can FDG PET/CT find a strong enough evidence-base to be practised clinically as an adjunct?

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 12/2014

Assessment of aortitis by semiquantitative analysis of 180-min 18F-FDG PET/CT acquisition images

Intraoperative 3-D imaging improves sentinel lymph node biopsy in oral cancer

Young Investigators Meeting 2014 Uta Eberlein, YIM’14 Award Winner

Comparison of the prognostic values of 68Ga-DOTANOC PET/CT and 18F-FDG PET/CT in patients with well-differentiated neuroendocrine tumor

What parameters from 18F-FDG PET/CT are useful in evaluation of adrenal lesions?

Sylvia H. Heywang-Koebrunner, Ingrid Schreer and Susan Barter (Eds): Diagnostic Breast Imaging: Mammography, Sonography, Magnetic Resonance Imaging and Interventional Procedures, 3rd edn